Category: News Alert

News Alert

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

December 14, 2023 Rich Daly, Editor in Chief Views

HRSA released a new web page with resources on the agency's 340B program patient definition and compliance guidelines.

In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Influential Senator Extends 340B Inquiry to Community Health Centers

November 16, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) expanded his ongoing inquiry into 340B revenue with letters to two major contract pharmacies.

The top Republican on an influential Senate committee today asked two community health centers to submit detailed financial information on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Medicare to Continue ASP Plus 6% for 340B Drugs in 2024

November 3, 2023 Rich Daly, Editor in Chief Views

In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.

Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Finalizes 340B Lump Sum Payment, Retains Offsetting Cuts Starting in 2026

November 2, 2023 Rich Daly, Editor in Chief Views

CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.

Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

November 1, 2023 Tom Mirga, Editor at Large Views

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.

Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

October 31, 2023 William Newton, Associate Editor/Senior Writer Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

October 19, 2023 Rich Daly, Editor in Chief Views

HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.

A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk Files Suit to Block $100,000 Arkansas Fine for 340B Contract Pharmacy Violations

October 13, 2023 William Newton, Associate Editor/Senior Writer Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

Danish drug giant Novo Nordisk filed suit Thursday to stop a proposed $100,000 fine from Arkansas over alleged violations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees

October 6, 2023 Tom Mirga, Editor at Large Views

Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.

Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Ranking GOP Senator on Key Committee Opens Investigation into 340B Hospital Revenue

September 29, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.

The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live